Male Fistula Repair
Male genitourinary fistula repair is dominated by iatrogenic disease — most cases arise as complications of prostate cancer treatment (radical prostatectomy, radiation, energy ablation) or inflammatory bowel disease (diverticulitis, Crohn's). The recurring decisions are route (transperineal vs. transabdominal vs. transanal vs. combined), timing relative to fecal / urinary diversion, interposition flap need (gracilis vs. rectus abdominis vs. omentum), and whether extirpative surgery with permanent diversion is the better primary endpoint.
Decision Framework
Male fistulas are overwhelmingly iatrogenic — most arise as complications of prostate cancer treatment (radical prostatectomy, radiation, energy ablation) or inflammatory bowel disease (diverticulitis, Crohn's). Pooled prevalence of radiation-induced fistula after prostate-cancer radiotherapy is ~0.2% but the consequences are devastating (Sadighian 2023). The dominant types reflect male pelvic anatomy: rectourethral (RUF), enterovesical / colovesical (EVF / CVF), urosymphyseal / puboprostatic (USF / PPF), urethrocutaneous (UCF), and radiation-induced complex anterior urinary fistula. The single most consequential variable is prior radiation — non-irradiated fistulas approach near-100% success with appropriate technique, while post-radiation cases require complex multimodality care, frequently end in extirpative surgery, and have substantially higher rates of permanent diversion and incontinence.
Identify the Fistula Type
| Presentation | Most Likely Fistula | Key Diagnostic Test |
|---|---|---|
| Pneumaturia + fecaluria + recurrent UTI after prostate cancer treatment | RUF (rectourethral) | Cystourethroscopy + proctoscopy; VCUG; MRI |
| Pneumaturia + fecaluria + recurrent UTI in a patient with diverticulitis or Crohn's | EVF / CVF (enterovesical / colovesical) | CT abdomen-pelvis; cystoscopy; colonoscopy; poppy-seed test (94.6% sensitivity) |
| Debilitating pubic / groin pain after pelvic RT + endoscopic BNC treatment | USF / PPF (urosymphyseal / puboprostatic) | MRI (critical); CT (gas in symphysis); bone cultures (80% positive) |
| Urinary leakage through penile / scrotal / perineal skin opening | UCF (urethrocutaneous) | Physical exam; retrograde urethrogram; cystourethroscopy |
| Urine drainage to the thigh or pubic skin after prostate-cancer RT | Radiation-induced anterior urinary fistula | CT; MRI; fistulogram |
Rectourethral Fistula (RUF) Decision Algorithm
| Clinical Scenario | Recommended Intervention | Key Considerations |
|---|---|---|
| Small RUF, no fecaluria, post-RP | Conservative: urethral catheter ± SPC drainage | May heal spontaneously; close monitoring |
| RUF with fecaluria, post-RP | Fecal diversion (colostomy) + urinary catheter → observe 3–6 mo | 33% heal with diversion alone; if persistent → surgical repair |
| Persistent non-irradiated RUF | Transperineal repair + gracilis flap (Lahey approach) | 95–100% success (Vanni 2010, Sbizzera 2022); colostomy may not be mandatory; BMG if concurrent stricture |
| Small RUF (≤ 1.5 cm), non-irradiated, no fecaluria | Transanal minimally invasive repair (MITAR / TAMIS) | 100% success in selected patients (Nicita 2017); no colostomy needed; ~58 min OR, 1.5-day LOS |
| Non-irradiated post-RARP RUF | York-Mason transsphincteric repair ± dartos flap | 100% success as first surgical intervention (van der Graaf 2025; Dafnis 2024); direct visualization |
| RUF with concurrent posterior urethral stenosis | Transperineal RUF repair + simultaneous posterior urethroplasty (anastomotic or BMG) + gracilis flap | 87% success (Khouri 2024 Cleveland Clinic series, n = 23); urethral stenosis should NOT preclude restorative surgery |
| Post-radiation / energy-ablation RUF | Transperineal repair + gracilis flap; consider abdominoperineal approach for complex cases | 84–87% success; 31% need permanent fecal diversion; 35% post-op incontinence (Harris 2017 multi-institutional, n = 201) |
| Complex post-radiation RUF with cavitation, failed repair, non-functioning bladder | Extirpative surgery (cystoprostatectomy) + permanent dual urinary diversion | 50% of post-radiation patients ultimately require this (Martins 2021); legitimate primary endpoint, not a failure |
Enterovesical / Colovesical Fistula (EVF / CVF) Decision Algorithm
| Clinical Scenario | Recommended Intervention | Key Considerations |
|---|---|---|
| CVF from diverticulitis, no abscess / obstruction | One-stage sigmoidectomy + primary anastomosis; Foley catheter alone for the bladder | Procedure of choice; bladder repair usually unnecessary (Ferguson 2008 — 68% Foley-only with equivalent outcomes); Froiio 2022 meta — Clavien ≥ 3 7.4%, mortality 1.5%, recurrence 0.5% |
| CVF from diverticulitis, fit for MIS | Robotic or laparoscopic sigmoidectomy + primary anastomosis | Sassun 2025 robotic series (n = 89): 1% conversion / 1% recurrence at 16.5 mo |
| CVF with abscess or obstruction | Staged procedure: diversion → resection → anastomosis | Multi-stage for complicated presentations |
| EVF in Crohn's disease | Resection of affected bowel + primary bladder closure (2 layers) ± omental patch | 90% require surgery (Solem 2002, Gruner 2002); 96% durable remission; cystectomy not needed |
| CVF from colorectal cancer | Oncologic resection with en bloc fistula excision; may require partial cystectomy | Must exclude malignancy preop; staged if metastatic |
| Patient unfit for surgery | Medical management with antibiotics | Preferable to diverting colostomy alone (which does not resolve fistula) |
Urosymphyseal / Puboprostatic Fistula (USF / PPF) Decision Algorithm
USF / PPF is a distinct entity arising almost exclusively from pelvic radiotherapy combined with subsequent endoscopic BNC manipulation. Conservative management does not resolve symptoms and is not recommended as definitive treatment (Andrews 2021).
| Clinical Scenario | Recommended Intervention | Key Considerations |
|---|---|---|
| USF with limited bone involvement | Pubic symphysis debridement + fistula closure + rectus abdominis interposition flap | 100% closure at 27 mo (Kaufman 2016 organ-sparing series, n = 4); avoids cystectomy |
| USF with extensive osteomyelitis | Pubectomy + urinary reconstruction (continent or incontinent diversion) | Pain resolution 96%; ECOG PS 3 → 0 (Andrews 2021); major complications 32% |
| USF with non-functioning bladder or extensive tissue destruction | Cystectomy + ileal conduit diversion | Required in 53–83% of patients (Bugeja 2016, Walach 2024); definitive |
Urethrocutaneous Fistula (UCF) Decision Algorithm
In adults, UCF is most commonly a sequela of failed childhood hypospadias surgery (Aldamanhori 2018 — fistula in 12.5–19% of adult hypospadias repairs); other causes include post-urethroplasty complications and gender-affirming genital surgery (metoidioplasty / phalloplasty).
| Clinical Scenario | Recommended Intervention | Key Considerations |
|---|---|---|
| Simple UCF (single, small) | Simple closure + de-epithelialized skin advancement flap | 93–96% success (Santangelo 2003); outpatient; catheter may not be needed (Sen 2007) |
| Recurrent UCF after failed conventional repair | PATIO technique (Preserve And Turn Inside Out) or TVF / scrotal dartos flap | PATIO 100% in salvage after failed standard (Singh 2022); TVF / scrotal dartos 94–95% (Choudhury 2023 meta) |
| UCF from failed hypospadias repair | Two-stage urethroplasty with buccal mucosa graft | 76% overall success including redo (Myers 2012; Morrison 2018); BMG superior to skin grafts |
| Penoscrotal UCF | De-epithelialized scrotal flap reinforcement | 0% recurrence (Lee 1990, n = 8); can be done without diversion |
| Multilayer closure for tension issues | Multilayer direct closure with longitudinal relaxing incision | 100% in 46 fistulas / 34 patients (Chen 2020) |
Radiation-Induced Complex Anterior Urinary Fistula
Distinct entity — fistulation from the urinary tract anteriorly to pubic symphysis (61%), thigh (38%), or perineal skin after pelvic radiotherapy for prostate cancer. TURNS multicenter (n = 31, Osterberg 2017): 19/31 underwent cystectomy, 12/31 underwent fistula repair (most with rectus abdominis interposition); 84% pain resolution at 6 mo, only 1 recurrence (managed with subsequent cystectomy).
Universal Principles & Cross-Cutting Decisions
For universal surgical principles (tension-free / watertight closure, tissue-interposition selection, postoperative drainage, repair timing, the "first operation is the best chance" rule), and for cross-cutting topics like preoperative urinary + fecal diversion, post-repair incontinence (37–61% after RUF), and AUS planning, see the Principles of Fistula Repair article. For male SUI / AUS pathways after fistula closure, see the Male SUI page.
Treatment Database
| Technique | Fistula Type | Best for / indication |
|---|---|---|
| Conservative Management | Rectourethral Fistula | Trial × 3–6 mo; fecaluria mandates colostomy; spontaneous closure 33–47% with diversion. |
| Transperineal Approach to RUF | Rectourethral Fistula | Gold standard — gracilis interposition; ~100% non-radiated / ~84% radiated; concurrent urethroplasty possible. |
| York-Mason Repair | Rectourethral Fistula | Small, non-radiated, first-time RUF — 80–100% closure with 0% fecal incontinence. |
| Endorectal Advancement Flap | Rectourethral Fistula | Small (<1.5 cm), non-radiated, iatrogenic RUF — simplest sphincter-preserving option (67–80%). |
| Transanal Minimally Invasive Repair | Rectourethral Fistula | Small non-radiated RUF — MITAR / TAMIS / R-TAMIS / TEM. Avoid biologic mesh. |
| Transabdominal Repair | Rectourethral Fistula | Complex RUF — radiated, intact prostate needing salvage RP, concurrent VUAS, high or recurrent. |
| Turnbull-Cutait Pull-Through | Rectourethral Fistula | Salvage for radiation RUF with severe proctitis or failed prior repairs — last option before permanent diversion. |
| Permanent Dual Diversion | Rectourethral Fistula | Radiated / multi-operated RUF where reconstruction is futile — 86% colostomy / 93% urinary in radiated. |
| Fecal Diversion | Rectourethral Fistula | Adjunct or definitive; non-radiated 91–97% reversal vs radiated 83–86% permanent colostomy. |
| Rectovesical Fistula Repair | Rectovesical Fistula | Transabdominal repair with cystotomy closure + omental interposition; higher location favors abdominal route. |
| Enterovesical / Colovesical Fistula Repair | Enterovesical / Colovesical Fistula | One-stage sigmoidectomy + Foley alone in 68% (Ferguson); MIS preferred; Crohn's: anti-TNF first. |
| Salvage Prostatectomy for USF | Urosymphyseal / Puboprostatic Fistula | Prostate in situ with adequate bladder for USF; BNC closure plus diversion or anastomosis. |
| Organ-Sparing Repair with Interposition Flap | Urosymphyseal / Puboprostatic Fistula | Localized anterior USF with intact bladder + viable sphincter — pubectomy + primary closure + flap; 100% (Kaufman). |
| Primary Repair (No Flap) | Urosymphyseal / Puboprostatic Fistula | Reserve for USF cases where no interposition flap is feasible. |
| Cystectomy + Ileal Conduit | Urosymphyseal / Puboprostatic Fistula | Non-functioning bladder or extensive destruction — 86% of irradiated USF (Patel). |
| Simple Closure + Skin Advancement Flap | Urethrocutaneous Fistula | First-time, small-to-moderate fistulas — 95.7% success; outpatient, no diversion needed (Santangelo / Belman). |
| Double Dartos Flap | Urethrocutaneous Fistula | First-line UCF coverage in primary distal hypospadias repair. |
| Tunica Vaginalis Flap | Urethrocutaneous Fistula | Recurrent UCF, proximal hypospadias, or repeat surgery; also corporeal graft for severe chordee. |
| PATIO Repair | Urethrocutaneous Fistula | Small UCF (<4 mm); tissue-sparing tract inversion as day-case without catheter. |
| Scrotal Flaps | Urethrocutaneous Fistula | UCF coverage when TVF is unavailable, after prior inguinal surgery. |
| Urethroperineal Fistula Repair | Urethroperineal Fistula | Congenital or acquired urethroperineal fistula; transperineal repair with flap interposition. |